These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18419441)

  • 1. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
    Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E
    Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T; Ismid IS; Rückert P; Fischer P
    Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.
    Turner JD; Mand S; Debrah AY; Muehlfeld J; Pfarr K; McGarry HF; Adjei O; Taylor MJ; Hoerauf A
    Clin Infect Dis; 2006 Apr; 42(8):1081-9. PubMed ID: 16575724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior killing of intracellular bacteria Wolbachia reduces inflammatory reactions and improves antifilarial efficacy of diethylcarbamazine in rodent model of Brugia malayi.
    Shakya S; Bajpai P; Sharma S; Misra-Bhattacharya S
    Parasitol Res; 2008 Apr; 102(5):963-72. PubMed ID: 18180957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis.
    Sanprasert V; Sujariyakul A; Nuchprayoon S
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):800-12. PubMed ID: 21073054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
    Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V
    Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
    McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
    Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India.
    Gayen P; Nayak A; Saini P; Mukherjee N; Maitra S; Sarkar P; Sinha Babu SP
    Acta Trop; 2013 Feb; 125(2):150-6. PubMed ID: 23123345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
    King CL; Suamani J; Sanuku N; Cheng YC; Satofan S; Mancuso B; Goss CW; Robinson LJ; Siba PM; Weil GJ; Kazura JW
    N Engl J Med; 2018 Nov; 379(19):1801-1810. PubMed ID: 30403937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
    Gunawardena S; Sri Ranganathan S; Fernandopulle R
    Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
    Rizzo JA; Belo C; Lins R; Dreyer G
    Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Kirodian BG; Ingole NS; Mehendale AM; Fleckenstein L; Karbwang J; Lazdins-Helds JK
    Trans R Soc Trop Med Hyg; 2004 Apr; 98(4):205-17. PubMed ID: 15049459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting reduction of Brugia timori microfilariae following a single dose of diethylcarbamazine combined with albendazole.
    Fischer P; Djuardi Y; Ismid IS; Rückert P; Bradley M; Supali T
    Trans R Soc Trop Med Hyg; 2003; 97(4):446-8. PubMed ID: 15259479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.